CATALAYER NEWS
GSK cancer drug clears rectal tumours in 76% of patients in trial, data shows
Source: Investing.com · 2026-10-26
Full article text is available in the Catalayer news terminal.
MORE FROM INVESTING.COM
BioNTech, DualityBio cancer drug trial meets primary endpoint
2026-10-26
Volkswagen partners with NXP for vehicle chip technology
2026-10-26
Why is Borr Drilling stock sliding today?
2026-10-26
Why is Panoro Energy stock sliding today?
2026-10-26
Earnings call transcript: Nitro Games Q3 2026 shares fall as strategy shift continues
2026-10-26
RELATED MARKETS
Prediction Markets